PMC:7556165 / 74426-74699
Annnotations
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T441 | 0-273 | Sentence | denotes | Remarkably, the same group demonstrated that overexpression of ACE2 promotes the expression of E-cadherin at expenses of mesenchymal markers such as vimentin, and thereby inhibits the epithelial-mesenchymal transition in NSCLC models (Feng et al., 2010; Qian et al., 2013). |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 2042 | 63-67 | Gene | denotes | ACE2 | Gene:70008 |
| 2043 | 95-105 | Gene | denotes | E-cadherin | Gene:999 |
| 2044 | 149-157 | Gene | denotes | vimentin | Gene:7431 |
| 2055 | 221-226 | Disease | denotes | NSCLC | MESH:D002289 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T6499 | 63-67 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
| T6500 | 95-105 | Protein | denotes | E-cadherin | https://www.uniprot.org/uniprot/Q9UII8|https://www.uniprot.org/uniprot/Q9R0T4|https://www.uniprot.org/uniprot/Q9JIV9|https://www.uniprot.org/uniprot/Q91709|https://www.uniprot.org/uniprot/Q6R8F2|https://www.uniprot.org/uniprot/Q61377|https://www.uniprot.org/uniprot/Q5RAX1|https://www.uniprot.org/uniprot/Q4PJ14|https://www.uniprot.org/uniprot/Q16194|https://www.uniprot.org/uniprot/Q15855|https://www.uniprot.org/uniprot/Q14216|https://www.uniprot.org/uniprot/Q13799|https://www.uniprot.org/uniprot/P30944|https://www.uniprot.org/uniprot/P12830|https://www.uniprot.org/uniprot/P09803|https://www.uniprot.org/uniprot/P08641|https://www.uniprot.org/uniprot/O35794|https://www.uniprot.org/uniprot/F1PAA9|https://www.uniprot.org/uniprot/A8K1U7 |
| T6519 | 149-157 | Protein | denotes | vimentin | https://www.uniprot.org/uniprot/Q9NTM3|https://www.uniprot.org/uniprot/Q9MZA9|https://www.uniprot.org/uniprot/Q96ML2|https://www.uniprot.org/uniprot/Q92155|https://www.uniprot.org/uniprot/Q91023|https://www.uniprot.org/uniprot/Q8N850|https://www.uniprot.org/uniprot/Q8CCH1|https://www.uniprot.org/uniprot/Q6LER9|https://www.uniprot.org/uniprot/Q5R1W8|https://www.uniprot.org/uniprot/Q548L2|https://www.uniprot.org/uniprot/Q4R4X4|https://www.uniprot.org/uniprot/Q3HWE4|https://www.uniprot.org/uniprot/Q17QM7|https://www.uniprot.org/uniprot/Q15869|https://www.uniprot.org/uniprot/Q15868|https://www.uniprot.org/uniprot/Q15867|https://www.uniprot.org/uniprot/P84198|https://www.uniprot.org/uniprot/P48674|https://www.uniprot.org/uniprot/P48670|https://www.uniprot.org/uniprot/P48616|https://www.uniprot.org/uniprot/P31000|https://www.uniprot.org/uniprot/P20152|https://www.uniprot.org/uniprot/P09654|https://www.uniprot.org/uniprot/P08670|https://www.uniprot.org/uniprot/P02544|https://www.uniprot.org/uniprot/P02543|https://www.uniprot.org/uniprot/O08704|https://www.uniprot.org/uniprot/F1RWC0|https://www.uniprot.org/uniprot/F1RWB8|https://www.uniprot.org/uniprot/D3DRU4|https://www.uniprot.org/uniprot/B0YJC2|https://www.uniprot.org/uniprot/A5A6N8 |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T484 | 95-105 | Body_part | denotes | E-cadherin | http://purl.org/sig/ont/fma/fma61792 |
| T485 | 149-157 | Body_part | denotes | vimentin | http://purl.org/sig/ont/fma/fma67330 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T443 | 221-226 | Disease | denotes | NSCLC | http://purl.obolibrary.org/obo/MONDO_0005233 |
LitCovid-sample-PD-GO-BP-0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T173 | 184-217 | http://purl.obolibrary.org/obo/GO_0001837 | denotes | epithelial-mesenchymal transition |
LitCovid-sample-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T179 | 184-217 | http://purl.obolibrary.org/obo/GO_0001837 | denotes | epithelial-mesenchymal transition |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T88 | 221-226 | Phenotype | denotes | NSCLC | http://purl.obolibrary.org/obo/HP_0030358 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2042 | 63-67 | Gene | denotes | ACE2 | Gene:70008 |
| 2043 | 95-105 | Gene | denotes | E-cadherin | Gene:999 |
| 2044 | 149-157 | Gene | denotes | vimentin | Gene:7431 |
| 2055 | 221-226 | Disease | denotes | NSCLC | MESH:D002289 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T441 | 0-273 | Sentence | denotes | Remarkably, the same group demonstrated that overexpression of ACE2 promotes the expression of E-cadherin at expenses of mesenchymal markers such as vimentin, and thereby inhibits the epithelial-mesenchymal transition in NSCLC models (Feng et al., 2010; Qian et al., 2013). |